Not all individuals with CLL have to have therapy. Regardless of all latest innovations, the iwCLL still recommends watchful observation for sufferers with asymptomatic disorder.86 This advice relies on at least two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 The two trials concluded https://jeffv367wyz1.bloginder.com/profile